Profil
Andrew McNeill is an Investor Director at Cumulus Oncology Ltd. He is also an Investor Director at Dxcover Ltd. and a Managing Partner at EOS Syndicate Management Ltd. Previously, he served as the Chairman of Chromacity Ltd. from 2017 to 2019.
Mr. McNeill completed his undergraduate degree at the University of Leeds in 2003.
Postes actifs de Andrew McNeill
| Sociétés | Poste | Début |
|---|---|---|
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Private Equity Investor | 01/11/2017 |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Directeur de la Recherche - Actions | - |
Dxcover Ltd.
Dxcover Ltd. Medical SpecialtiesHealth Technology Manufactures hardware and develops artificial intelligence based software for early detection of cancers | Private Equity Investor | 01/03/2019 |
Anciens postes connus de Andrew McNeill
| Sociétés | Poste | Fin |
|---|---|---|
Chromacity Ltd.
Chromacity Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and supplies ultrafast fibre lasers | Président | 01/11/2019 |
Formation de Andrew McNeill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Finance |
Chromacity Ltd.
Chromacity Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and supplies ultrafast fibre lasers | Health Technology |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Dxcover Ltd.
Dxcover Ltd. Medical SpecialtiesHealth Technology Manufactures hardware and develops artificial intelligence based software for early detection of cancers | Health Technology |
















